Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Camellia ptilophylla extract is derived from the leaves of Camellia ptilophylla, a unique species of tea plant commonly known as "cocoa tea." This plant is notable for its naturally low caffeine content and high levels of polyphenols and amino acids. The extract contains bioactive compounds such as gallocatechin-3,5-di-O-gallate and 1,2,4,6-tetra-O-galloyl glucose. Research indicates that Camellia ptilophylla extract exhibits antioxidant and anticancer properties in preclinical studies. Its mechanism of action is believed to involve free radical scavenging (antioxidant activity) and potential inhibition of cancer cell proliferation[1][4]. The primary use has been studied in the context of dietary supplementation or functional foods rather than as a pharmaceutical drug[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on camellia ptilophylla extract.